Platelet rich plasma, stromal vascular fraction and autologous conditioned serum in treatment of knee osteoarthritis
- 1 August 2018
- journal article
- review article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 104, 652-660
Abstract
No abstract availableKeywords
This publication has 108 references indexed in Scilit:
- Biomechanical considerations in the pathogenesis of osteoarthritis of the kneeKnee Surgery, Sports Traumatology, Arthroscopy, 2011
- Risk factors for incident osteoarthritis of the hip and kneeCurrent Reviews in Musculoskeletal Medicine, 2011
- Multipotent adipose stromal cells and breast cancer development: Think globally, act locallyMolecular Carcinogenesis, 2010
- Age-Related Changes in the Musculoskeletal System and the Development of OsteoarthritisClinics in Geriatric Medicine, 2010
- Oxidative Stress Inhibits Insulin-like Growth Factor-I Induction of Chondrocyte Proteoglycan Synthesis through Differential Regulation of Phosphatidylinositol 3-Kinase-Akt and MEK-ERK MAPK Signaling PathwaysJournal of Biological Chemistry, 2009
- Aging and osteoarthritis: the role of chondrocyte senescence and aging changes in the cartilage matrixOsteoarthritis and Cartilage, 2009
- The regenerative effect of platelet-rich plasma on healing in large osteochondral defectsInternational Orthopaedics, 2009
- Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part IIArthritis & Rheumatism, 2007
- Multilineage Cells from Human Adipose Tissue: Implications for Cell-Based TherapiesTissue Engineering, 2001
- Development of criteria for the classification and reporting of osteoarthritis: Classification of osteoarthritis of the kneeArthritis & Rheumatism, 1986